I believe most here will laugh at my projection for 2015 and the share price. I don't have time to break it completely down at the moment, and my revenue projections are higher than analysts for 2015, but I think it's reasonable to believe we could do revenue over $100 million by the end of the year. Most remember the first presentation Mr. Croxall put out there in 2013 I believe projecting over $100 million in 3 to 5 years. Well, as he stated in many conferences afterwards, that presentation/projections is useless at this point due to many significant portfolio additions. My target for end of the year - $30 per share, and I believe that's being conservative. My line of thinking, quickly, and possibly conservative figures:
Stryker settlement - $25-$45 million
other orthophoenix settlements - $15-$20 million
TPMS settlements - $20-$40 million
Apple settlement - $60-$80 million
other dynamic agreements - $50 million
possible RPX agreement for TLI - $20 million
possible RPX agreement for Vantage point - $20-$30 million
Celgene settlement - $100+ million
Total Signal IP settlements (conservative) $100 - $150 million
Sarif settlements - $25 million
+
Discount or eliminate two of these settlements (failed campaign, going all the way to trial, invalid patent, etc), and the projection still remains over $100 million. Nevermind the heart valve patents, newly acquired portfolios, new campaigns in Dynnamic, loopback, etc, Opus, and other unforeseen business route.
Also, Q4 will not be a telling quarter. I'm expecting revenue to come in lower than Q3, but that's not an issue due to the many markmans and trails this year. Q4 is simply irrelevant to me.
News 
Market Data 
Discover 
